These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 39186318)
21. CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study. Low A; Prats-Sedano MA; Stefaniak JD; McKiernan EF; Carter SF; Douvani ME; Mak E; Su L; Stupart O; Muniz G; Ritchie K; Ritchie CW; Markus HS; O'Brien JT J Neurol Neurosurg Psychiatry; 2022 May; 93(5):481-490. PubMed ID: 35135868 [TBL] [Abstract][Full Text] [Related]
22. The LIBRA Index in Relation to Cognitive Function, Functional Independence, and Psycho-Behavioral Symptoms in a Sample of Non-Institutionalized Seniors at Risk of Dementia. Franchini F; Musicco M; Ratto F; Storti G; Shofany J; Caltagirone C; Di Santo SG J Alzheimers Dis; 2019; 72(3):717-731. PubMed ID: 31640092 [TBL] [Abstract][Full Text] [Related]
23. Lifestyle for Brain Health (LIBRA): a new model for dementia prevention. Schiepers OJG; Köhler S; Deckers K; Irving K; O'Donnell CA; van den Akker M; Verhey FRJ; Vos SJB; de Vugt ME; van Boxtel MPJ Int J Geriatr Psychiatry; 2018 Jan; 33(1):167-175. PubMed ID: 28247500 [TBL] [Abstract][Full Text] [Related]
24. Social determinants and lifestyle factors for brain health: implications for risk reduction of cognitive decline and dementia. Röhr S; Pabst A; Baber R; Engel C; Glaesmer H; Hinz A; Schroeter ML; Witte AV; Zeynalova S; Villringer A; Löffler M; Riedel-Heller SG Sci Rep; 2022 Jul; 12(1):12965. PubMed ID: 35902604 [TBL] [Abstract][Full Text] [Related]
25. Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia. Mohanannair Geethadevi G; Quinn TJ; George J; Anstey KJ; Bell JS; Sarwar MR; Cross AJ Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014885. PubMed ID: 37265424 [TBL] [Abstract][Full Text] [Related]
26. Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer's disease and vascular dementia. Trares K; Stocker H; Stevenson-Hoare J; Perna L; Holleczek B; Beyreuther K; Schöttker B; Brenner H Alzheimers Res Ther; 2024 Aug; 16(1):188. PubMed ID: 39160600 [TBL] [Abstract][Full Text] [Related]
27. Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition. Stephen R; Liu Y; Ngandu T; Rinne JO; Kemppainen N; Parkkola R; Laatikainen T; Paajanen T; Hänninen T; Strandberg T; Antikainen R; Tuomilehto J; Keinänen Kiukaanniemi S; Vanninen R; Helisalmi S; Levälahti E; Kivipelto M; Soininen H; Solomon A J Alzheimers Dis; 2017; 59(2):695-705. PubMed ID: 28671114 [TBL] [Abstract][Full Text] [Related]
28. Midlife CAIDE dementia risk score and dementia-related brain changes up to 30 years later on magnetic resonance imaging. Vuorinen M; Spulber G; Damangir S; Niskanen E; Ngandu T; Soininen H; Kivipelto M; Solomon A J Alzheimers Dis; 2015; 44(1):93-101. PubMed ID: 25190628 [TBL] [Abstract][Full Text] [Related]
29. Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study-A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline. Röhr S; Zülke A; Luppa M; Brettschneider C; Weißenborn M; Kühne F; Zöllinger I; Samos FZ; Bauer A; Döhring J; Krebs-Hein K; Oey A; Czock D; Frese T; Gensichen J; Haefeli WE; Hoffmann W; Kaduszkiewicz H; König HH; Thyrian JR; Wiese B; Riedel-Heller SG Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33430189 [TBL] [Abstract][Full Text] [Related]
30. Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index. van Middelaar T; Hoevenaar-Blom MP; van Gool WA; Moll van Charante EP; van Dalen JW; Deckers K; Köhler S; Richard E Alzheimers Res Ther; 2018 Jun; 10(1):62. PubMed ID: 29960597 [TBL] [Abstract][Full Text] [Related]
31. Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index. Vos SJB; van Boxtel MPJ; Schiepers OJG; Deckers K; de Vugt M; Carrière I; Dartigues JF; Peres K; Artero S; Ritchie K; Galluzzo L; Scafato E; Frisoni GB; Huisman M; Comijs HC; Sacuiu SF; Skoog I; Irving K; O'Donnell CA; Verhey FRJ; Visser PJ; Köhler S J Alzheimers Dis; 2017; 58(2):537-547. PubMed ID: 28453475 [TBL] [Abstract][Full Text] [Related]
32. Utility of the LIBRA Index in Relation to Cognitive Functioning in a Clinical Health Seeking Sample. Pons A; LaMonica HM; Mowszowski L; Köhler S; Deckers K; Naismith SL J Alzheimers Dis; 2018; 62(1):373-384. PubMed ID: 29439337 [TBL] [Abstract][Full Text] [Related]
33. Gender and Educational Differences in the Association between Lifestyle and Cognitive Decline over 10 Years: The Doetinchem Cohort Study. Deckers K; Nooyens A; van Boxtel M; Verhey F; Verschuren M; Köhler S J Alzheimers Dis; 2019; 70(s1):S31-S41. PubMed ID: 30507570 [TBL] [Abstract][Full Text] [Related]
34. CAIDE Dementia Risk Score, Alzheimer and cerebrovascular pathology: a population-based autopsy study. Hooshmand B; Polvikoski T; Kivipelto M; Tanskanen M; Myllykangas L; Mäkelä M; Oinas M; Paetau A; Solomon A J Intern Med; 2018 Jun; 283(6):597-603. PubMed ID: 29411449 [TBL] [Abstract][Full Text] [Related]
35. The CAIDE Dementia Risk Score App: The development of an evidence-based mobile application to predict the risk of dementia. Sindi S; Calov E; Fokkens J; Ngandu T; Soininen H; Tuomilehto J; Kivipelto M Alzheimers Dement (Amst); 2015 Sep; 1(3):328-33. PubMed ID: 27239514 [TBL] [Abstract][Full Text] [Related]
36. Midlife risk score for the prediction of dementia four decades later. Exalto LG; Quesenberry CP; Barnes D; Kivipelto M; Biessels GJ; Whitmer RA Alzheimers Dement; 2014 Sep; 10(5):562-70. PubMed ID: 24035147 [TBL] [Abstract][Full Text] [Related]
37. Higher midlife CAIDE score is associated with increased brain atrophy in a cohort of cognitively healthy middle-aged individuals. Liu X; Dounavi ME; Ritchie K; Wells K; Ritchie CW; Su L; Muniz-Terrera G; O'Brien JT J Neurol; 2021 May; 268(5):1962-1971. PubMed ID: 33423129 [TBL] [Abstract][Full Text] [Related]
38. Adherence to a lifestyle intervention - just a question of self-efficacy? Analysis of the AgeWell.de-intervention against cognitive decline. Wittmann FG; Pabst A; Zülke A; Luppa M; Oey A; Boekholt M; Weise S; Fankhänel T; Kosilek RP; Brettschneider C; Döhring J; Lunden L; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG Alzheimers Res Ther; 2024 Jun; 16(1):133. PubMed ID: 38909256 [TBL] [Abstract][Full Text] [Related]
39. Association of LIfestyle for BRAin health risk score (LIBRA) and genetic susceptibility with incident dementia and cognitive decline. Neuffer J; Wagner M; Moreno E; Le Grand Q; Mishra A; Trégouët DA; Leffondre K; Proust-Lima C; Foubert-Samier A; Berr C; Tzourio C; Helmer C; Debette S; Samieri C Alzheimers Dement; 2024 Jun; 20(6):4250-4259. PubMed ID: 38775256 [TBL] [Abstract][Full Text] [Related]
40. Original research: initial development of a pragmatic tool to estimate cognitive decline risk focusing on potentially modifiable factors in Parkinson's disease. Carlisle TC; Medina LD; Holden SK Front Neurosci; 2023; 17():1278817. PubMed ID: 37942138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]